Eastman Chemical (EMN) Heads Into Results With An Undervalued Narrative Intact

Eastman Chemical approaches its Q3 2026 earnings release with shares trading 22% below estimated fair value. Analysts cite circular earnings growth and cost-saving initiatives as drivers for the current undervaluation narrative.